Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients

Journal of Thoracic Oncology

Volumn 9, Issue 3, 2014, Pages 337-344

  Matsumura, Yuki ^a   Hishida, Tomoyuki ^a   Shimada, Yoshihisa ^a   Ishii, Genichiro ^a   Aokage, Keiju ^a   Yoshida, Junji ^a   Nagai, Kanji ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Lymphatic permeation; Non small cell lung cancer; Prognostic factor; Surgery

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LONG TERM SURVIVAL; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH VESSEL METASTASIS; LYMPHATIC PARAMETERS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84894517502     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000073     Document Type: Article

References (21)

1. Maeda R, Yoshida J, Ishii G, et al. Long-Term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension. Chest 2010;138:357-362.
2. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification. Chest 2011;139:855-861.
3. Naito Y, Goto K, Nagai K, et al. Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer. Chest 2010;138:1411-1417.
4. Li Z, Yu Y, Lu J, et al. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China. J Thorac Oncol 2009;4:702-709.
5. Poncelet AJ, Cornet J, Coulon C, Collard P, Noirhomme P, Weynand B; groupe d'oncologie thoracique des Cliniques Saint-Luc. Intra-Tumoral vascular or perineural invasion as prognostic factors for long-Term survival in early stage non-small cell lung carcinoma. Eur J Cardiothorac Surg 2008;33:799-804.
6. Harada M, Hato T, Horio H. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer. J Thorac Oncol 2011;6:48-54.
7. Miyoshi K, Moriyama S, Kunitomo T, Nawa S. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:429-434.
8. Ruffini E, Asioli S, Filosso PL, et al. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: Did the 2009 7th edition of the TNM staging system miss something?. J Thorac Oncol 2011;6:319-326.
9. Shoji F, Haro A, Yoshida T, et al. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer. Ann Thorac Surg 2010;89:864-869.
10. Hishida T, Yoshida J, Maeda R, et al. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: Which indicator is the stronger prognostic factor?. Eur J Cardiothorac Surg 2013;43:772-777.
11. International Association for the Study of Lung Cancer. Staging Handbook in Thoracic Oncology. Orange Park, FL: Editorial Rx Press, 2009.
12. Saijo T, Ishii G, Ochiai A, et al. Evaluation of extratumoral lymphatic permeation in non-small cell lung cancer as a means of predicting outcome. Lung Cancer 2007;55:61-66.
13. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours, 7th Ed. International Union Against Cancer: Wiley, John & Sons, 2009.
14. Iwakiri S, Nagai S, Katakura H, et al. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung. Ann Surg Oncol 2009;16:1678-1685.
15. Takanami I. Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer. Oncol Rep 2006;15:437-442.
16. Aokage K, Ishii G, Ohtaki Y, et al. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2011;128:1585-1595.
17. Funai K, Sugimura H, Morita T, Shundo Y, Shimizu K, Shiiya N. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma. Ann Surg Oncol 2011;18:2968-2972.
18. Kozu Y, Maniwa T, Takahashi S, Isaka M, Ohde Y, Nakajima T. Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer. J Cardiothorac Surg 2013;8:106.
19. Renyi-Vamos F, Tovari J, Fillinger J, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005;11:7344-7353.
20. Shimizu K, Yamada K, Saito H, et al. Surgically curable peripheral lung carcinoma: Correlation of thin-section CT findings with histologic prognostic factors and survival. Chest 2005;127:871-878.
21. Sakuma Y, Takeuchi T, Nakamura Y, et al. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src. J Pathol 2010;220:574-585.